BIVI Quote, Trading Chart, BioVie Inc
home / stock / bivi / bivi quote
$9.99 Last:
-20.08% Change Percent:
$10.5 Open:
$9.99 Previous Close:
$10.99 High:
$9.7 Low:
553,497 Volume:
09/18/2020 04:53:41 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
BIVI Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2020-09-18 | 10.5 | 9.99 | 10.99 | 9.7 | 553,497 |
| 2020-09-17 | 16.88 | 12.5 | 16.88 | 11.01 | 24,897 |
| 2020-09-16 | 16 | 15.7 | 16 | 15.1 | 5,615 |
| 2020-09-15 | 15.99 | 16.5 | 17.71 | 14.81 | 9,586 |
| 2020-09-14 | 16.5 | 15.25 | 16.5 | 15 | 11,730 |
| 2020-09-11 | 17.5 | 17.4 | 17.5 | 17 | 2,351 |
| 2020-09-10 | 19.12 | 18 | 19.12 | 15 | 3,220 |
| 2020-09-09 | 17.665 | 19 | 20 | 17.32 | 6,717 |
| 2020-09-08 | 19.13 | 17.5 | 19.13 | 17.5 | 4,213 |
| 2020-09-07 | 20 | 21.49 | 21.5 | 18.95 | 1,440 |
| 2020-09-04 | 20 | 21.49 | 21.5 | 18.95 | 1,440 |
| 2020-09-03 | 19.5 | 19.95 | 19.95 | 18.58 | 1,208 |
| 2020-09-02 | 20 | 20 | 20.31 | 20 | 2,284 |
| 2020-09-01 | 20.06 | 20 | 21.07 | 20 | 1,300 |
| 2020-08-31 | 21.14 | 21 | 21.15 | 21 | 2,217 |
| 2020-08-28 | 25 | 21.06 | 25 | 21.06 | 1,740 |
| 2020-08-27 | 22 | 25 | 25 | 22 | 4,413 |
| 2020-08-26 | 20.01 | 20.01 | 20.01 | 20.01 | 270 |
| 2020-08-25 | 24 | 24 | 24.5 | 23 | 3,036 |
| 2020-08-24 | 26.5 | 24 | 27.5 | 24 | 5,327 |
BioVie Inc Company Name:
BIVI Stock Symbol:
OTC Market:
News, Short Squeeze, Breakout and More Instantly...
-
CARSON CITY, Nev., June 23, 2022 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative disorders, today announced t...
-
CARSON CITY, Nev., April 25, 2022 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative dis...
-
CARSON CITY, Nev., March 10, 2022 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI), a clinical-stage company developing innovative drug therapies for the treatment of advanced liver disease and neurological and neurodegenerative disorders, today announced that an interview with Presi...